Interactive Panel Discussion & Q&A: De-risking Oncology Drug Discovery for Targeted Degradation
Time: 6:40 pm
day: De-risking Drug Development to Ensure Success Before Entering the Clinic
Details:
- Review how assay development and reagent selection can influence go- and no-go decisions prior to advancing a TPD or RNAi candidate into the clinic
- Discuss the challenges, strategies and best practices when it comes to confident results interpretation of efficacy and safety of drug candidates
More speakers TBC!
